Anagrelide Hydrochloride
- Product NDC
- 0172-5240
- 11-digit product format
- 001725240
- Labeler code
- 0172
- Product ID
- 0172-5240_fc800314-47d7-41ca-af8a-9222fbf5631c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anagrelide Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA076468
- Marketing category
- ANDA
- Marketing start
- 2005-04-18
- Marketing end
- 0000-00-00
- Substance
- ANAGRELIDE HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ANAGRELIDE HYDROCHLORIDE | ACTIVE INGREDIENT | VNS4435G39 | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| ANAGRELIDE | ACTIVE MOIETY | K9X45X0051 | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| Anagrelide Hydrochloride | ACTIVE INGREDIENT | VNS4435G39 | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| Anagrelide | ACTIVE MOIETY | K9X45X0051 | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0172-5240 | ANAGRELIDE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA, INC.] | 26 | Legacy NDC | 20250529_6727d5d4-e8ec-4a85-bc82-ec70b641eecf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0172-5240-60 | 00172524060 | 100 CAPSULE in 1 BOTTLE (0172-5240-60) | 100 capsule | 2005-04-18 | 0000-00-00 | No | No | Current |